Literature DB >> 2282462

Structure-activity studies on endothelin (16-21), the C-terminal hexapeptide of the endothelins, in the guinea-pig bronchus.

P Rovero1, R Patacchini, C A Maggi.   

Abstract

1. We describe the results of a structure-activity study in which the C-terminal hexapeptide of the endothelins, endothelin (16-21), is compared with shorter fragments; hexapeptides bearing amino-acid substitutions and the corresponding C-terminal fragments of sarafotoxins. The guinea-pig bronchus was used in this study since it is the most sensitive preparation for endothelin (16-21) thus far developed. 2. The biological results obtained with endothelin (16-21) and analogues demonstrate that the contractile activity of the C-terminal hexapeptide of endothelin on the guinea-pig bronchus depends on quite close structural requirements, strongly suggestive of a receptor interaction. The following features appear to be essential for the biological activity: (a) the C-terminal free carboxylic function; (b) the L-configuration of Trp-21; (c) the beta-carboxylic function of Asp-18; (d) the presence of Leu-17 and (e) the imidazole moiety of His-16. 3. The hexapeptide corresponding to the C-terminal portion of sarafotoxin, sarafotoxin (16-21), was devoid of biological activity. This behaviour might be related to the proposed existence of more than one receptor for the endothelin/sarafotoxin family in the guinea-pig bronchus.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2282462      PMCID: PMC1917644          DOI: 10.1111/j.1476-5381.1990.tb12119.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  28 in total

1.  Effects of endothelin on regional hemodynamics in conscious rats.

Authors:  S P Han; A J Trapani; K F Fok; T C Westfall; M M Knuepfer
Journal:  Eur J Pharmacol       Date:  1989-01-17       Impact factor: 4.432

2.  Sarafotoxin, a novel vasoconstrictor peptide: phosphoinositide hydrolysis in rat heart and brain.

Authors:  Y Kloog; I Ambar; M Sokolovsky; E Kochva; Z Wollberg; A Bdolah
Journal:  Science       Date:  1988-10-14       Impact factor: 47.728

3.  Effects of endothelin on the renal artery from spontaneously hypertensive and Wistar Kyoto rats.

Authors:  Y Tomobe; T Miyauchi; A Saito; M Yanagisawa; S Kimura; K Goto; T Masaki
Journal:  Eur J Pharmacol       Date:  1988-08-02       Impact factor: 4.432

4.  Endothelin, a novel vasoconstrictor peptide, as potent bronchoconstrictor.

Authors:  Y Uchida; H Ninomiya; M Saotome; A Nomura; M Ohtsuka; M Yanagisawa; K Goto; T Masaki; S Hasegawa
Journal:  Eur J Pharmacol       Date:  1988-09-13       Impact factor: 4.432

5.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells.

Authors:  M Yanagisawa; H Kurihara; S Kimura; Y Tomobe; M Kobayashi; Y Mitsui; Y Yazaki; K Goto; T Masaki
Journal:  Nature       Date:  1988-03-31       Impact factor: 49.962

6.  Structure-activity relationships of endothelin: importance of the C-terminal moiety.

Authors:  S Kimura; Y Kasuya; T Sawamura; O Shinmi; Y Sugita; M Yanagisawa; K Goto; T Masaki
Journal:  Biochem Biophys Res Commun       Date:  1988-11-15       Impact factor: 3.575

7.  Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor.

Authors:  G de Nucci; R Thomas; P D'Orleans-Juste; E Antunes; C Walder; T D Warner; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

8.  Further studies on the response of the guinea-pig isolated bronchus to endothelins and sarafotoxin S6b.

Authors:  C A Maggi; S Giuliani; R Patacchini; P Santicioli; A Giachetti; A Meli
Journal:  Eur J Pharmacol       Date:  1990-01-25       Impact factor: 4.432

9.  Competitive interaction between endothelin and sarafotoxin: Binding and phosphoinositides hydrolysis in rat atria and brain.

Authors:  I Ambar; Y Kloog; I Schvartz; E Hazum; M Sokolovsky
Journal:  Biochem Biophys Res Commun       Date:  1989-01-16       Impact factor: 3.575

10.  Rat endothelin is a vasodilator in the isolated perfused mesentery of the rat.

Authors:  T D Warner; G de Nucci; J R Vane
Journal:  Eur J Pharmacol       Date:  1989-01-17       Impact factor: 4.432

View more
  5 in total

1.  Prediction of location of active sites in biologically active peptides.

Authors:  T Kikuchi
Journal:  J Protein Chem       Date:  1996-08

Review 2.  Understanding Peptide Binding in Class A G Protein-Coupled Receptors.

Authors:  Irina G Tikhonova; Veronique Gigoux; Daniel Fourmy
Journal:  Mol Pharmacol       Date:  2019-07-10       Impact factor: 4.436

3.  X-ray structures of endothelin ETB receptor bound to clinical antagonist bosentan and its analog.

Authors:  Wataru Shihoya; Tomohiro Nishizawa; Keitaro Yamashita; Asuka Inoue; Kunio Hirata; Francois Marie Ngako Kadji; Akiko Okuta; Kazutoshi Tani; Junken Aoki; Yoshinori Fujiyoshi; Tomoko Doi; Osamu Nureki
Journal:  Nat Struct Mol Biol       Date:  2017-08-14       Impact factor: 15.369

4.  Endothelin (16-21): biphasic effect and no desensitization on the guinea-pig isolated ileum.

Authors:  N Miasiro; C R Nakaie; A C Paiva
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

5.  Development of agonists of endothelin-1 exhibiting selectivity towards ETA receptors.

Authors:  Chantal Langlois; Myriam Létourneau; Philipe Lampron; Véronique St-Hilaire; Alain Fournier
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.